Glenmark Pharma launches antidiabetic injectable

Glenmark Pharma launches antidiabetic injectable

Glenmark Pharmaceuticals has launched the first biosimilar of the popular anti-diabetic drug, Liraglutide in India, which will lower the therapy cost by approximately 70%. The drug is being marketed under the brand Lirafit, following an approval from the Drug Controller General of India. It is priced around Rs 100 for a standard dose of 1.2 … Read more

As Ozempic use grows, poison centre calls in Canada jump for injectable weight-loss drugs – National

As Ozempic use grows, poison centre calls in Canada jump for injectable weight-loss drugs – National

As drugs like Ozempic and Wegovy rise in popularity, there have been increased calls about injectable drugs often used for weight loss to some poison control centres in parts of Canada, according to data gathered by Global News. These come from people experiencing adverse side effects from the medications, or even what some officials consider … Read more